Drugs / Lu AG06479
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04473651 | Jul 2020 → Nov 2021 | — | H. Lundbeck A/S | Terminated | No outcome recorded Stop: Business |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lu AG06479 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04473651 ↗ |
| Route | Oral | “capsules, orally (Part A and B)” NCT04473651 ↗ |